Bart Swinkels part 5: Differences between Europe and the US: Patenting DNA sequences and antibodies

Just like for medical science, the patentability of biomedical inventions is subject to continuous change and amendments in laws and regulations. In this video, Bart discusses two examples: genomic DNA sequences and monoclonal antibodies. In the next week (no. 2) we will address the patenting of DNA in more detail. In week 5 you will work on a case study in which the patenting of antibodies is the main focus.